Protocol: Benefits and harms of remdesivir for COVID-19 in adults: A systematic review with meta-analysis

BACKGROUND: Effective drug treatments for Covid-19 are needed to decrease morbidity and mortality for the individual and to alleviate pressure on health care systems. Remdesivir showed promising results in early randomised trials but subsequently a large publicly funded trial has shown less favourab...

Descripción completa

Detalles Bibliográficos
Autores principales: Paludan-Müller, Asger Sand, Lundh, Andreas, Page, Matthew J., Munkholm, Klaus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8629254/
https://www.ncbi.nlm.nih.gov/pubmed/34843589
http://dx.doi.org/10.1371/journal.pone.0260544

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8629254/
https://www.ncbi.nlm.nih.gov/pubmed/34843589
http://dx.doi.org/10.1371/journal.pone.0260544

Ejemplares similares